Literature DB >> 3298433

Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

T Yoshimura, K Matsushima, J J Oppenheim, E J Leonard.   

Abstract

LPS stimulated human blood mononuclear leukocytes to produce a chemotactic factor for human neutrophils. The effect of LPS was dose-dependent; 10 micrograms/ml was optimal for production of chemotactic factor. Chemotactic activity was detected 3 hr after LPS stimulation, and reached its peak at 12 hr. No activity was detected in culture supernatants of unstimulated cells, provided LPS-free media were selected. Isoelectric point of the factor, determined by chromatofocusing, was approximately 8 to 8.5. Molecular weight was approximately 10 kilodaltons by Sephacryl S-200 gel filtration or by HPLC gel filtration on TSK-2000 and -3000 columns in succession. The gel filtration fractions were also assayed for IL 1 activity. The elution position of IL 1 activity corresponded to a m.w. of 18. There was no chemotactic activity in the IL 1 activity peak. Furthermore, highly purified natural Il 1 alpha and -beta and recombinant Il 1 alpha and -beta did not exhibit chemotactic activity for neutrophils in our assay. Among mononuclear leukocytes, the monocyte was the principal producer of neutrophil chemotactic factor. These results suggest that a chemotactic factor for neutrophils, different from IL 1, is produced by LPS-stimulated blood monocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298433

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  143 in total

Review 1.  Through the looking glass: the diverse in vivo activities of chemokines.

Authors:  S L Kunkel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Chemokines. Introduction.

Authors:  K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

3.  The role of CD18 in IL-8 induced dermal and synovial inflammation.

Authors:  M J Forrest; G J Eiermann; R Meurer; L A Walakovits; D E MacIntyre
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

4.  Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.

Authors:  G J Zlabinger; K M Stuhlmeier; R Eher; S Schmaldienst; R Klauser; A Vychytil; B Watschinger; O Traindl; J Kovarik; E Pohanka
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

5.  Exposure to in utero lipopolysaccharide induces inflammation in the fetal ovine skin.

Authors:  Matthew W Kemp; Masatoshi Saito; Ilias Nitsos; Alan H Jobe; Suhas G Kallapur; John P Newnham
Journal:  Reprod Sci       Date:  2010-10-05       Impact factor: 3.060

6.  Identification and characterization of macrophage inflammatory protein 2.

Authors:  S D Wolpe; B Sherry; D Juers; G Davatelis; R W Yurt; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Sean-Paul Nuccio; Takeshi Haneda; Maria G Winter; R Paul Wilson; Joseph M Russell; Thomas Henry; Quynh T Tran; Sara D Lawhon; Gabriel Gomez; Charles L Bevins; Holger Rüssmann; Denise M Monack; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  A synthetic analog of the 3-deoxy-D-manno-2-octulosonic acid disaccharide moiety of rough-type endotoxins does not bind to mouse peritoneal macrophages and human monocytes.

Authors:  R Girard; T Pedron; P Kosma; R Chaby
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.

Authors:  Li-Bing Liu; Feng Xie; Kai-Kai Chang; Ming-Qing Li; Yu-Han Meng; Xiao-Hui Wang; Hui Li; Da-Jin Li; Jin-Jin Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat.

Authors:  K P Meyers; C L Czachowski; J W Coffey
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.